Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study - Concepedia

Concepedia

Publication | Open Access

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

DOI Full Paper Access

121

Citations

26

References

2020

Year

Lowell L. Hart, Renata Ferrarotto, Zoran Andrić, J. Thaddeus Beck, Janakiraman Subramanian, Davorin Radosavljević, Bojan Zarić, Wahid T. Hanna, Raid Aljumaily, Taofeek K. Owonikoko,

Advances in Therapy

References

	Year	Citations

Page 1